Latest News of MIRM
Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
3 months ago
Mirum Pharmaceuticals is a biopharmaceutical company specializing in novel therapies for rare diseases. Their lead product is LIVMARLI for cholestatic pruritus in Alagille syndrome....
Mirum Pharmaceuticals (NASDAQ:MIRM) delivers shareholders solid 23% CAGR over 5 years, surging 11% in the last week alone
By Yahoo! Finance |
4 months ago
Investing in shares carries risks, but can also lead to substantial gains. Mirum Pharmaceuticals saw its share price increase by 185% in the last five years. Although the company didn't profit recentl...